CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Obalon Therapeutics, Inc. vs. POLYZEN, INC.

Explore the PTAB proceeding IPR2017-00813 filed by Obalon Therapeutics, Inc. on 2017-01-30. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2017-00813

Filing Date

2017-01-30

Accorded Filing Date

2017-01-30

Institution Decision Date

β€”

Last Modified Date

2017-10-23

Proceeding Type

IPR

Termination Date

2017-08-21

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 10815282
Respondent Patent Number 7883491
Legal Expiration Date
2026-12-10 Expiring Soon (20 days)
Patent Term Adjustment (PTA) +983 Days Awarded
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred
Respondent Inventor Tilak M. Shah
Respondent Tech Center TC 1700 - Chemical & Materials Engineering

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1700 - Chemical & Materials Engineering

Decisions Rendered

1 Total

Proceeding Status

Terminated-Settled

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Settlement before Institution 2017-08-21
Dismissing the Proceedings
35 USC 318, 37 CFR 42.5, 37 CFR 42.74, 35 USC 317

Address and Attorney/Agent Information

1 Registered Practitioner

Power of Attorney & Correspondence

Firm / Entity Name HULTQUIST IP
Customer Number 23448
Address P.O. BOX 14329, RESEARCH TRIANGLE PARK, NC, 27709, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
28021 Steven Hultquist +1 919-419-9350

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 1 proceeding
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡ͺπŸ‡Ί Europe πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2017-01-30
IPR2017-00812

Obalon Therapeutics, Inc. v. Polyzen, Inc.

U.S. Continuation Sibling (7682306)
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

29
14

Notice of Refund Paper

2017-08-30 FILING PARTY: BOARD
13

Petitioner's Request for Refund Paper

2017-08-22 FILING PARTY: PETITIONER
12

Dismissing the Proceedings Paper

2017-08-21 FILING PARTY: BOARD
11

Joint Motion to Keep Separate Paper

2017-08-18 FILING PARTY: PETITIONER
10

Joint Motion to Terminate Proceeding Paper

2017-08-18 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc